The First Affiliated Hospital of Nanchang University — Nanchang

Public research footprint of The First Affiliated Hospital of Nanchang University, compiled from the ClinicalTrials.gov public registry.

681

Registered studies

403

Active

240

Recruiting now

158

Completed

Stopped or withdrawn

Most-studied conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Non-small Cell Lung Cancer · Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · Hormone Receptor Positive HER-2 Negative Breast Cancer

Recently updated registry entries

NCT07219966 — A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder (Recruiting)
NCT07218341 — A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… (Recruiting)
NCT04221542 — Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The First Affiliated Hospital of Nanchang University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.